Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Brm/Brg1 ATP inhibitor-1 | 2270879-17-7 | 99.7% | 10 MG
SDP

Supplier:  Medchemexpress LLC HY11937410MG

Encompass_Preferred

BRM/BRG1 ATP inhibitor-1 is an orally active, allosteric small-molecule inhibitor that selectively targets the ATPase activity of BRM (SMARCA2) and BRG1 (SMARCA4). It demonstrates sub-nanomolar potency and has shown anticancer activity in preclinical studies, making it useful for epigenetic and chromatin remodeling research.

  • Potent allosteric dual inhibitor of BRM and BRG1 ATPase activity.
  • Sub-nanomolar potency (IC50 < 0.005 μM) for both targets.
  • High purity suitable for biochemical and cell-based assays.
  • Available in solid and solution formats, including 10 mg solid and 10 mM in DMSO.
  • Recommended storage conditions preserve stability (powder: -20°C; in solvent: -80°C).

Catalog No. 50-002-33236


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.